Fukawa Akiko
Faculty of Nursing, Osaka Medical College, Osaka, Japan.
Asia Pac J Oncol Nurs. 2021 Jan 29;8(2):180-187. doi: 10.4103/apjon.apjon_58_20. eCollection 2021 Mar-Apr.
Recently, Japan has seen an increase in the number of elderly patients with lung cancer, and oral molecularly targeted therapy has become an increasingly common treatment option for these patients. Accordingly, we have developed the Self-Management Support Program for Elderly Patients with Lung Cancer who are Receiving Molecularly-Targeted Therapy. The purpose of this study is to evaluate this program based on the responses of nurses to a survey regarding the program's usability by general nurses.
We developed the program based on our previous study and the existing literature. To evaluate the program, general nurses interested in caring for elderly patients with lung cancer or patients with other forms of cancer receiving oral agents, took part in the survey about the program's appropriateness and usefulness.
Twenty-seven nurses took part in the survey. More than 90% of nurses agreed or slightly agreed with these statements: "the purpose of the program is appropriate," "the program is suitable for patients," "The program is useful for general nurses," and "The program is useful for nurses in providing patient support." However, some of them commented, "Nurses do not have enough time to answer outpatients' queries" and "I'm afraid that general nurses can't use this program, because they don't have enough knowledge about lung cancer patients and oral agents."
The study demonstrated that the self-management support program was appropriate. Further studies are necessary to modify this program to make it useful for nurses in the clinical setting. To further examine its effectiveness, in future, the program needs to be made available to elderly patients with lung cancer who are receiving molecularly targeted therapy with oral agents in the outpatient department.
近年来，日本老年肺癌患者数量有所增加，口服分子靶向治疗已成为这些患者越来越常见的治疗选择。因此，我们为接受分子靶向治疗的老年肺癌患者开发了自我管理支持项目。本研究的目的是根据护士对该项目可用性的调查反馈来评估该项目。
我们基于之前的研究和现有文献开发了该项目。为评估该项目，对护理老年肺癌患者或接受口服药物治疗的其他癌症患者感兴趣的普通护士参与了关于该项目适宜性和实用性的调查。
27名护士参与了调查。超过90%的护士同意或基本同意以下表述：“该项目的目的恰当”、“该项目适合患者”、“该项目对普通护士有用”以及“该项目对护士提供患者支持有用”。然而，他们中的一些人评论道：“护士没有足够时间回答门诊患者的询问”以及“我担心普通护士无法使用这个项目，因为他们对肺癌患者和口服药物了解不足”。
该研究表明自我管理支持项目是恰当的。有必要进一步开展研究对该项目进行改进，使其在临床环境中对护士有用。为进一步检验其效果，未来需要将该项目提供给在门诊接受口服分子靶向治疗的老年肺癌患者。
